Medtronic Buys Kanghui To Expand Orthopedic Market Presence In China
This article was originally published in The Gray Sheet
Executive Summary
Medtronic acquires the second largest orthopedic company in China on Sept. 27, gaining a strong local operation in the country and leaving the future of Medtronic’s 2007 ortho joint venture with Weigao uncertain.
You may also be interested in...
‘Made In China’ Provision Removed From Green Channel Policy
The original draft of an accelerated approval policy in China for innovative devices included a condition that a product being considered for the special pathway “is produced in China.” That condition has been removed from the latest draft following pressure from the U.S. government.
Medtronic Emphasizes International Growth Opportunities
Medtronic is betting on emerging markets and the “value” market to be its major growth drivers over the next few years.
Medtronic Ups Stake In China Cardiac Market With LifeTech Investment
The $66 million deal gives Medtronic a significant stake in LifeTech, a Chinese developer of minimally invasive devices, including balloon catheters, delivery systems, occluders and stent graft systems.